Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Non-responder status
At the time of writing, prices were about $150 for a 10 mg vial or $250 for a 50 mg vial
announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
Structure Therapeutics Sector: Oral small molecule GLP-1 receptor agonists for obesity HQ: San Francisco, CA Year Founded: 2016 (as Eccogene
MT-I (afamelanotide), not MT-II
US$ 26.16
US$ 20.48
US$ 29.26
US$ 26.78
